PamelaLynKunzMD
Oncology • North Haven, CTGastrointestinal Cancer
Associate Professor, Medicine - Oncology, Yale Cancer Center
Dr. Kunz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Smilow Cancer Hospital - Yale North Haven
6 Devine Street
North Haven, CT 06473Phone+1 203-200-4422Fax+1 203-200-6950
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2008- Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2004 - 2005
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2001 - 2004
Geisel School of Medicine at DartmouthClass of 2001
Certifications & Licensure
CA State Medical License 2002 - 2026
CT State Medical License 2020 - 2026
NY State Medical License 2024 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
- A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors Start of enrollment: 2009 Mar 01
- Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms.Johannes Uhlig, James Nie, Joanna Gibson, Michael Cecchini, Stacey Stein
Scientific Reports. 2024-12-17 - Modern Management of Gastric Neuroendocrine Neoplasms.John W Kunstman, Anil Nagar, Joanna Gibson, Pamela L Kunz
Current Treatment Options in Oncology. 2024-09-01 - 18 citations[Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gas...Simron Singh, Daniel Halperin, Sten Myrehaug, Ken Herrmann, Marianne Pavel
Lancet. 2024-06-29
Press Mentions
Common Cancer Type Could Be Detected with New Blood TestFebruary 4th, 2025- Can Aspirin Improve Colorectal Cancer Outcomes?February 3rd, 2025
- Daily Aspirin Reduces Colon Cancer Risk, Study ShowsJanuary 29th, 2025
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
